Trials of India�s first mRNA Covid vaccine by Gennova on track

Khyati Shah01 Jun, 2021Business

Gennova Biopharmaceuticals, which is working on India?s first mRNA Covid-19 vaccine, is in the midst of Phase-I trials of its Covid-19 vaccine (HGC019). Vikas Thapar, president ? corporate development & strategy, Emcure Pharmaceuticals, said the Phase-I trials will be completed in the next 45-60 days. Phase-II trials will resume after that and take a similar time frame, he added. Gennova is a biotech subsidiary of Pune-based Emcure Pharmaceuticals.